Description

RAD-150 (TLB-150) ZPHC — 20 mg (100 Tablets × 20 mg)

Pharma-grade RAD-150 (TLB-150) – 100 tablets × 20 mg

RAD-150, also known as TLB-150 Benzoate, represents a significant advancement in research compounds within the selective androgen receptor modulator (SARM) class. This esterified analogue of RAD-140 (Testolone) is designed for researchers investigating tissue-selective anabolic activity and pharmacokinetic optimization.

Product Highlights

Extended Half-Life for Research Protocols
The benzoate ester modification of RAD-150 results in an estimated elimination half-life of approximately 48 hours, compared to 16-20 hours for non-esterified RAD-140. This extended half-life makes RAD-150 particularly suitable for research protocols requiring stable plasma concentrations and reduced dosing frequency in long-term studies.

High-Purity Pharmaceutical Grade
Each ZPHC batch undergoes rigorous laboratory testing to confirm greater than 99% purity. Comprehensive quality control includes heavy-metal screening and microbiological clearance to ensure research-grade standards.

Precise 20 mg Dosing
Scored and film-coated tablets allow for precise dose adjustment, including easy splitting for 10 mg dosing protocols. This formulation supports consistent and accurate administration in research settings.

Minimal Water Retention Profile
The compound’s properties promote a dry physiological response, making it particularly relevant for research into body recomposition and metabolic studies during caloric restriction phases.

Authenticity and Quality Assurance
Each product comes in sealed blisters within a tamper-evident box featuring a scratch-code authenticity system. Tracked worldwide shipping ensures secure delivery.

Technical Specifications

Research Applications

RAD-150 is primarily indicated for laboratory research investigating:

• Tissue-selective androgen receptor modulation

• Muscle anabolic pathways in chronic dosing models

• Pharmacokinetic properties of esterified SARMs

• Metabolic stability and tissue distribution kinetics

Recommended Research Protocols

For laboratory research applications, typical protocols employ dosages ranging from 10-30 mg daily over 6-8 week study periods. The compound can be combined with other research agents such as Ligandrol or low-dose testosterone in combination studies.

Researchers should note that the esterification of RAD-150 significantly alters its pharmacokinetic profile compared to RAD-140. Direct dose equivalence between the two compounds cannot be assumed in research protocols.

Storage and Handling

Store in a cool, dry environment away from direct sunlight. For optimal stability, research suggests storage at -20°C for powder form and appropriate DMSO storage conditions for solution preparations.

---

Top 10 Frequently Asked Questions

1. What is the difference between RAD-150 and RAD-140?
RAD-150 (TLB-150 Benzoate) is the esterified derivative of RAD-140 (Testolone). The addition of a benzoate ester increases lipophilicity and extends the elimination half-life from approximately 16-20 hours to approximately 48 hours. This pharmacokinetic modification alters tissue distribution kinetics and metabolic stability.

2. What is the half-life of RAD-150?
RAD-150 has an estimated elimination half-life of approximately 48 hours, approximately 2.5-3 times longer than RAD-140. This extended half-life allows for less frequent dosing in research protocols.

3. What purity standards does ZPHC RAD-150 meet?
ZPHC batches are lab-tested to greater than 99% purity. Quality control includes heavy-metal screening and microbiological clearance to ensure research-grade standards.

4. Is RAD-150 approved for human consumption?
No SARM has been approved for human consumption and these compounds cannot be legally marketed as such. RAD-150 is supplied exclusively for laboratory research purposes.

5. What is the recommended research dosage range?
Typical research protocols employ doses ranging from 10-30 mg daily over 6-8 week study periods. The scored tablets allow for easy splitting to achieve 10 mg dosing.

6. How does esterification affect the compound’s properties?
Esterification increases lipophilicity (LogP = 5.4), which alters tissue distribution kinetics and extends the elimination half-life. The benzoate ester also influences compound stability under storage conditions and requires product-specific handling protocols.

7. Can RAD-150 be directly substituted for RAD-140 in research?
Generic substitution between RAD-150 and RAD-140 is scientifically invalid due to fundamental differences in chemical structure, pharmacokinetic profile, and metabolic stability conferred by benzoate esterification. Direct dose-equivalence substitution should not be assumed.

8. What are the potential side effects in research models?
Based on available research, potential effects may include suppression of natural testosterone production, cardiovascular effects, and other androgen-related responses. Researchers should monitor subjects carefully and implement appropriate recovery protocols.

9. What is post-cycle therapy and is it necessary?
Post-cycle therapy is a structured protocol designed to restore natural hormonal balance after compound administration. It is considered an important component of responsible research protocols to help maintain research outcomes and minimize extended hormone deficiencies.

10. How should RAD-150 be stored?
For optimal stability, research suggests storage at -20°C for powder form. For solution preparations, DMSO solutions may be stored at 4°C for up to 2 weeks or -80°C for up to 6 months. Always store away from direct sunlight and moisture.

---

Purchase and Authenticity

This product is supplied in sealed blisters within a tamper-evident box featuring scratch-code authenticity verification. Tracked worldwide shipping ensures secure delivery to research facilities.

Order RAD-150 ZPHC 20 mg (100 Tablets) today at https://anabolicsteroidsonline.shop/